Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts

[1]  V. Mautner,et al.  MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro , 2017, PloS one.

[2]  V. Mautner,et al.  TUMORIGENESIS AND NEOPLASTIC PROGRESSION The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells , 2017 .

[3]  J. Field,et al.  Comprehensive pharmacological profiling of neurofibromatosis cell lines. , 2017, American journal of cancer research.

[4]  A. Lazar,et al.  Targeting Group I p21-Activated Kinases to Control Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis , 2017, Oncogene.

[5]  Elizabeth E. Sweeney,et al.  Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors , 2016, Scientific Reports.

[6]  M. Tainsky,et al.  Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors , 2016, Oncotarget.

[7]  E. Pasmant,et al.  Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells , 2016, Oncotarget.

[8]  R. Martuza,et al.  Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus. , 2014, Neuro-oncology.

[9]  N. M. Powell,et al.  Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity , 2014, Oncotarget.

[10]  A. Kurtz,et al.  Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs) , 2013, Journal of Neuro-Oncology.

[11]  L. Zelek,et al.  Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review , 2013, Orphanet Journal of Rare Diseases.

[12]  Jeffrey K. Mito,et al.  NF1 Deletion Generates Multiple Subtypes of Soft-Tissue Sarcoma That Respond to MEK Inhibition , 2013, Molecular Cancer Therapeutics.

[13]  Siddikuzzaman,et al.  Evaluation of immunomodulatory and antitumor activity of all trans retinoic acid (ATRA) in solid tumor bearing mice , 2013, Immunopharmacology and immunotoxicology.

[14]  G. Page,et al.  MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. , 2013, The Journal of clinical investigation.

[15]  B. Aronow,et al.  Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target , 2012, Clinical Cancer Research.

[16]  Yunhui Liu,et al.  All-trans retinoic acid enhances bystander effect of suicide-gene therapy against medulloblastomas , 2011, Neuroscience Letters.

[17]  S. Rabkin,et al.  Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors , 2011, PloS one.

[18]  M. van Glabbeke,et al.  First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  Jan Koster,et al.  NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome , 2010, Cell.

[20]  A. Deimling,et al.  Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model , 2010, Journal of Neuro-Oncology.

[21]  L. Qin,et al.  Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Jan Koster,et al.  ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. , 2009, Cancer cell.

[23]  S. Singer,et al.  Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells , 2008, Molecular Cancer Therapeutics.

[24]  T. Crombleholme,et al.  Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors. , 2008, Cancer research.

[25]  A. Boddy,et al.  The Role of the , 1934 .

[26]  F. Mandelli,et al.  Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. , 2006, Cancer research.

[27]  A. von Deimling,et al.  Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity. , 2006, Carcinogenesis.

[28]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[29]  S. Fosså,et al.  Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Debiec‐Rychter,et al.  Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients , 2004, Neurobiology of Disease.

[31]  K. Becker,et al.  Transcriptional profiling in an MPNST-derived cell line and normal human Schwann cells. , 2004, Neuron glia biology.

[32]  A. Guha,et al.  Malignant peripheral nerve sheath tumors. , 2004, Neurosurgery clinics of North America.

[33]  D. Gutmann,et al.  International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. , 2002, Cancer research.

[34]  C. Fletcher.  Soft tissue tumours , 1989 .

[35]  B. Scheithauer,et al.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases , 1986, Cancer.

[36]  A. Templeton.  Soft tissue tumours. , 1973, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.